Alprolix infusion?

Alprolix (eftrenonacog alfa) is a recombinant factor IX Fc fusion protein used for prevention of bleeding (prophylaxis) and for treatment/management of bleeds in people with hemophilia B. It is given by intravenous (IV) infusion.

What you might be looking for
- Indications: routine prophylaxis to prevent bleeding in adults and children with hemophilia B; treatment/control of bleeds; perioperative prophylaxis.
- How it’s given: IV infusion, usually into a vein. Dosing is based on body weight and the level of factor IX activity your doctor wants to achieve. Some people are treated in a clinic; others who are trained may infuse at home.
- Common dosing patterns (these are general guidelines; your exact dose and schedule should come from your healthcare provider):
- Prophylaxis (preventing bleeds) in adults/adolescents: often 25–40 IU/kg once weekly, or 50–75 IU/kg every 2 weeks (your doctor may choose one of these schedules or adjust based on how well you maintain factor IX levels and bleeding frequency).
- Prophylaxis in some patients who need higher trough levels or less frequent infusions: 50–75 IU/kg every 2 weeks is sometimes used.
- On-demand/bleed treatment: doses in the range of 20–60 IU/kg per dose, given every 12–24 hours or as directed by your clinician, until bleeding is controlled.
- Important: The exact dose and how often you infuse are individualized. Follow your doctor’s instructions and the product labeling.

Infusion instructions (general)
- Preparation: Reconstitute the powder with the supplied sterile diluent using aseptic technique. Do not shake; mix gently until the solution is clear.
- Administration: Draw the reconstituted solution into a syringe and infuse IV. The rate is usually rapid for small volumes (often around 1–2 minutes for typical dose sizes), but your clinician will tell you the appropriate rate.
- Post-infusion: Flush the IV line with sterile saline if advised, and monitor for any signs of an adverse reaction (hives, trouble breathing, dizziness, chest tightness, swelling, etc.).

Storage and handling
- Store in a refrigerator (2–8°C) until use. Do not freeze.
- After reconstitution, solutions are typically stable for a limited time at room temperature (the label will specify; often a few hours). Do not use past the labeled expiration time.
- Keep out of reach of children.

Safety and considerations
- Inhibitors: Some people with hemophilia B can develop neutralizing antibodies (inhibitors) to factor IX, which can reduce effectiveness. Your healthcare provider will monitor for this.
- Allergic reactions: Seek immediate medical attention if you have symptoms of a severe allergic reaction after a dose (rash, swelling, trouble breathing).
- Thrombosis: Elevated factor IX levels can theoretically increase the risk of blood clots, especially if given too much or in people with certain risk factors. Your clinician will weigh risks.
- Special situations: Pregnancy, breastfeeding, or planned surgery should be discussed with your physician.

If you’d like, tell me:
- Are you looking for dosing guidance (prophylaxis vs. on-demand) based on your weight or age?
- Do you want a step-by-step summary of reconstitution and infusion?
- Do you have the exact product labeling or a pharmacy insert you want me to interpret?

I can tailor the information to your situation and help interpret the prescribing information.